Inhibitor May Turn Tumor-Protecting Immune Cells Against Glioblastoma

Mayo Clinic researchers find possible new approach to brain tumor treatment

The preclinical research, published in Nature Communications last month, is on glioblastoma, an aggressive form of brain cancer.

Inhibitor may turn tumor-protecting immune cells against glioblastoma

Mayo Clinic researchers have identified a potential new approach to treating glioblastoma that could help the immune system fight the aggressive brain cancer while improving the effectiveness of existing chemotherapy.

Reprogramming immune cells boosts chemotherapy response in brain cancer,

The human brain has long been considered the body’s ultimate sanctuary, a fortress protected by barriers and immune privileges that keep threats at bay. Yet glioblastoma, the most common and aggressive cancerous brain tumor in adults, has learned to weaponize this very protection. Rather than merely evading the immune system, glioblastoma actively recruits and reshapes […]

Mayo Clinic Researchers Find a Way to Reprogram Immune Cells and Boost Chemotherapy Response in Glioblastoma

Mayo Clinic researchers have identified a potential new approach to treating glioblastoma that could help the immune system fight the aggressive brain cancer while improving the effectiveness of existing chemotherapy.